Vincent Coljee

Vincent Coljee is currently the DNA Core Manager at Addgene and serves as a Visiting Scholar in the Harvard Physics Department, where they conduct groundbreaking research in the biophysics of DNA. Previously, Vincent co-founded Excelimmune, Inc., serving as Chief Scientific Officer from 2006 to 2012, where they raised over $25 million and established platform technologies and teams within the company. Vincent also held the position of Chief Scientific Officer at Inovan Inc. from 2019 to 2022 and was a Consultant and Chief Technology Officer at Abveris in 2018. Prior to that, as a Senior Scientist at Symphogen A/S from 2000 to 2005, they contributed significantly by authoring a white paper that laid the foundation for the company's platform development.